The GOP is renewing its focus on the abortion pill
Three Republican-led states are taking another crack at suing the FDA over the abortion pill, mifepristone

Since the end of Roe. v. Wade, the abortion drug mifepristone has increasingly become a flashpoint between pro-life and pro-choice advocates. Four months after the Supreme Court rejected a lawsuit to reverse changes by the Food and Drug Administration that made the drug more widely accessible, a group of conservative states is taking another crack at bringing the issue back to court.
Abortion pills are back on the chopping block
The attorneys general of three GOP-led states — Missouri, Idaho, and Kansas — have banded together to revive and file a new lawsuit against the FDA. The suit hopes to reverse several regulatory changes the agency has made since 2016 that greatly expanded access to mifepristone. The states claim they have standing to sue because the FDA's actions violate state abortion laws by "enabling an out-of-state abortion drug distribution network." In addition to some of the points revived from the first case, the new lawsuit seeks to outlaw giving the medication to anyone under 18. It also wants to tamp down on the "fast-growing practice of prescribing abortion pills through telemedicine and mailing them to patients," including to states with abortion bans, said The New York Times.
The original lawsuit, which was filed in 2022 by anti-abortion doctors and groups, was unanimously rejected by the Supreme Court. The plaintiffs had no standing to sue the FDA because they "do not prescribe or use mifepristone" themselves and were instead trying to regulate the actions of others, Justice Brett Kavanaugh said in the court's opinion in the case. Last year, Missouri, Idaho, and Kansas petitioned to join the suit at the lower court level and were granted the status of intervenors. After the court dismissed the original case, they filed an amended complaint as plaintiffs.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The attorneys general also argued that mailing abortion pills violates the Comstock Act, a "19th-century law that's laid dormant for decades that bans the mailing of anything related to abortion," said Forbes. If they successfully convince the court, the ruling could "help anti-abortion rights advocates use that law to ban abortion more broadly." The act bans not just mailing the pills but any equipment related to abortion. It has been viewed as a "potential way for Republicans to functionally outlaw abortion without imposing a federal ban," as it would make it "largely impossible to perform the procedure."
'A nakedly political and judge-shopping ploy'
The states might have a slight edge over the original plaintiffs regarding having the standing to take on the FDA. Still, their ability to claim the FDA is harming them could face substantial challenges, David S. Cohen, a law professor at Drexel University, said to the Times. It is also questionable that the states filed in the same court where the original group was rejected. "It is a nakedly political and judge-shopping ploy," Cohen said. If Missouri, Idaho, and Kansas are "really are harmed by these pills," they should file in their states. But they want to appear before U.S. District Judge Matthew Kacsmaryk, a Trump appointee, so they can "piggyback on this lawsuit that had no standing in the first place, and that shouldn't be allowed."
It is ironic that the states' invocation of the Comstock Act "represents a deliberate effort to upend their sovereign authority over abortion," Shoshanna Ehrlich said at Ms. Magazine. In doing so, they are "calling upon the power of federal law to cut off access to medication abortion in states where abortion is legal — thus upending their sovereign authority." The right's "relentless post-Dobbs crusade" to block access to abortion "represents a power grab by states aimed at forcing pregnant people, including teens, to bear children by legal fiat."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
Why is Netanyahu pushing into the West Bank now?
TODAY'S BIG QUESTION Israeli tanks have entered some Palestinian cities for the first time in decades. What's behind this latest assault on the occupied territory, and where could it lead if left unchecked?
By Rafi Schwartz, The Week US Published
-
What is Mark Cuban's net worth?
In Depth Not every Trump-era billionaire has gone full MAGA
By David Faris Published
-
Musk vs. Altman: The fight over OpenAI
Feature Elon Musk has launched a $97.4 billion takeover bid for OpenAI
By The Week US Published
-
Amy Gleason: the low-profile Trump insider officially heading DOGE
IN THE SPOTLIGHT While Elon Musk continues slashing government services as Trump's 'efficiency' pitbull, the White House insists a little-known MAGA functionary is the one officially running DOGE
By Rafi Schwartz, The Week US Published
-
House passes framework for big tax and spending cuts
Speed Read Democrats opposed the GOP's plan for $4.5 trillion in tax cuts and $2 trillion in spending cuts, citing the impacts it will have on social programs
By Peter Weber, The Week US Published
-
GOP: Is Medicaid on the chopping block?
Feature
By The Week US Published
-
Trump's 'radical' plans for the FBI come into focus
IN THE SPOTLIGHT By placing far-right podcaster Dan Bongino in the agency's #2 spot, the president has made clear what he wants from the nation's premier law enforcement organization
By Rafi Schwartz, The Week US Published
-
Why are Republicans suddenly panicking about DOGE?
TODAY'S BIG QUESTION As Trump and Musk take a chainsaw to the federal government, a growing number of Republicans worry that the massive cuts are hitting a little too close to home
By Rafi Schwartz, The Week US Published
-
Mitch McConnell won't seek reelection
Speed Read The longest-serving Senate party leader is retiring
By Rafi Schwartz, The Week US Published
-
Trump's Ukraine about-face puts GOP hawks in the hot seat
IN THE SPOTLIGHT The president's pro-Russia pivot has alienated allies, emboldened adversaries, and placed members of his party in an uncomfortable position
By Rafi Schwartz, The Week US Published
-
'There is a lot riding on the deal for both sides'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published